Sunesis Pharmaceuticals (SNSS) Misses Q2 EPS by 2c
Get Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
Other income (expense), net: 23K
Today's EPS Names:
SHIM, KOD, HEWA, More
Financial Fact:
Other income (expense), net: 23K
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q2 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $854 thousand versus the consensus estimate of $1.21 million.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Planet Labs (PL) Reports In-Line Q4 EPS, provides guidance
- Surf Air Mobility Inc. (SRFM) Reports revenue, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!